unknown
Stage
About
Hansa Biopharma develops immunomodulating therapies using proprietary antibody-cleaving enzymes to treat rare autoimmune diseases and enable desensitization in gene therapy and transplantation.
Explore Hansa Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.